FDA panel rejects brexpiprazole-sertraline combo for PTSD

Medscape | July 22, 2025


Clinicians are not convinced of the efficacy of the combination given the conflicting data. It would be “hard to translate the confusing contradictory datasets to my clinical practice,” says Murray Raskind, MD.